Hover a dot or row, or tab through the dots · bars scaled to the largest round ($24.3M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-562009
First filed2025-10-24
Latest2025-10-24
Sought$4.3M
Sold$4.3M
Investors131
Exemptions506(b)
021-468742
First filed2022-12-27
Latest2022-12-27
Sought$36.8M
Sold$18.5M
Investors51
Exemptions506(b)
021-389274
First filed2021-02-12
Latest2021-02-12
Sought$5M
Sold$750K
Investors4
Exemptions506(b)
021-359977
First filed2020-02-06
Latest2020-02-06
Sought$26.6M
Sold$24.3M
Investors140
Exemptions506(b)
Who backs EpiBone, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-10-24
Related persons
Name
Relationship
Nina Tandon
RelationshipExecutive Officer, Director
Sarindr Bhumiratana
RelationshipExecutive Officer, Director
Gordana Vunjak-Novakovic
RelationshipDirector
Robert Langer
RelationshipDirector
David Zhu
RelationshipDirector
Facts
As its latest Form D states them
Industry
Other
State
New York (NY)
Exemptions
Rule 506(b)
First filed
2020-02-06
Latest filing
2025-10-24
Who backs EpiBone, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)